Details

Autor(en) / Beteiligte

• Morse, Rachel M.
• Brown, Joanna
• Noble, Helen E.
• Ríos López, E. Jennifer
• Kohler-Smith, Anna
• Soto, Sandra
• del Cuadro, Daniel Lenin
• Gonzales Díaz, Karina
• Figueredo Escudero, Magaly
• Vásquez del Aguila, Giannina
• Carrillo Jara, Lita E.
• Silva Delgado, Hermann F.
• Palacios, Victor A.
• Santos-Ortiz, Carlos
• Gravitt, Patti E.
• Paz-Soldan, Valerie A.
• Del Carpio-Morgan, Meda
• Garcia Satalay, Esther Y.
• Gilman, Sarah D.
• Jerónimo, José
• Jorges, Alcedo
• Jurczuk, Magdalena
• Kosek, Margaret
• Ladrón de Guevarra, Gabriela
• Lopez Liñán, Renso
• Matos Orbegozo, Andrea
• Marín, Jaime
• Meza, Graciela
• Ríos Reátegui, Reyles
• Román, Karina
• Rositch, Anne F.
• Tangoa, Nolberto
• Vásquez Vásquez, Javier
• Zevallos, Karen

Titel

Women’s perspectives on the acceptability and feasibility of an HPV screen-and-treat approach to cervical cancer prevention in Iquitos, Peru: a qualitative study

Ist Teil von

• BMC women's health, 2022-10, Vol.22 (1), p.1-414, Article 414

Ort / Verlag

London: BioMed Central

Erscheinungsjahr

2022

Quelle

SpringerLink Journals - AutoHoldings

Beschreibungen/Notizen

• Abstract Background The objective of this study was to explore women’s experiences of a screen-and-treat approach with ablative therapy (referred to by the Spanish acronym TVT-TA) as a method of treatment following a positive HPV test in Iquitos, Peru. Methods A total of 111 in-depth interviews were conducted with 47 HPV positive women who attended the TVT-TA procedure at a primary-level healthcare facility. Interviews were conducted immediately before, immediately after, and six-weeks after TVT-TA. Results Most interviewed women reported experiencing moderate pain during ablative therapy and minimal pain immediately after and six weeks after ablative therapy. Women also stated that the pain was less intense than they had expected. The most common physical after-effects of treatment were bleeding and vaginal odor. Women experienced oscillating emotions with fear upon receiving a positive HPV result, calming after hearing about ablative therapy treatment, worry about pain from the treatment itself, relaxation with counseling about the procedure, and relief following treatment. Conclusions Nearly all participants emphasized that they were pleased with the TVT-TA process even if they had experienced pain during TVT-TA, recommended that TVT-TA be expanded and available to more women, and stated that TVT-TA was faster and easier than expected. This study found that TVT-TA is a feasible and acceptable means of treating HPV according to the women receiving the treatment.